CRA-2059 structure
|
Common Name | CRA-2059 | ||
---|---|---|---|---|
CAS Number | 256649-36-2 | Molecular Weight | 750.80 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C34H46N12O8 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of CRA-2059CRA-2059 is a highly specific and selective tryptase inhibitor, with a Ki of 620 pM for recombinant human tryptase-β (rHTβ)[1][2]. |
Name | CRA-2059 |
---|
Description | CRA-2059 is a highly specific and selective tryptase inhibitor, with a Ki of 620 pM for recombinant human tryptase-β (rHTβ)[1][2]. |
---|---|
Related Catalog | |
In Vitro | Tryptase is a trypsin-like serine protease found as a major protein component in human mast cell secretory granules. CRA-2059 has the potential for inflammatory bowel disease research[1]. |
References |
Molecular Formula | C34H46N12O8 |
---|---|
Molecular Weight | 750.80 |